AtheroNova
Gambling & Gaming · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2301 Dupont Dr Ste 525, Irvine, Californ...Phone Number
(949) 476-1100Website
www.atheronova.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About AtheroNova
AtheroNova Inc. is a biotechnology company focused on the discovery, research, development and licensing of novel compounds to safely reduce or regress atherosclerotic plaque deposits and improve lipid profiles in humans. In addition to its lead compound AHRO-001, AtheroNova plans to develop multiple applications for its patented and patents-pending therapies in market sectors that include: Cardiovascular Disease, Stroke and Peripheral Artery Disease, all of which have been linked to atherosclerosis. Atherosclerosis and its related pharmaceutical expenses for these indications cost consumers more than $41 billion annually in the United States alone.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AtheroNova your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if AtheroNova had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at AtheroNova
Check out if AtheroNova is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
AtheroNova, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on AtheroNova recently announced quarterly report
Funding: Get notified immidiatlly once AtheroNova has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when AtheroNova launches new products
Check if AtheroNova has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to AtheroNova
Compare insights from companies similar to AtheroNova, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
AtheroNova
<$5M
11-50
Private
<$5M
1997
N/A
AtheroNova financials insights
Gather financial insights about AtheroNova, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Debt
$1.9M
AtheroNova Tech Stack
A closer look at the technologies used by AtheroNova
See more technologies
Top Gambling & Gaming Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AtheroNova
Sign Up For FreeTo access detailed company insights
AtheroNova Inc. is a biotechnology company focused on the discovery, research, development and licensing of novel compounds to safely reduce or regress atherosclerotic plaque deposits and improve lipid profiles in humans. In addition to its lead compound AHRO-001, AtheroNova plans to develop multiple applications for its patented and patents-pendin... Read More
